Last updated: 2026-10-09 16:10:40. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Conexeu Sciences Inc. (CNXU) operates in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES sector and is listed on NASDAQ. The stock is currently priced at $4,16, with a market capitalization of $102,67M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3,05 to $18,79. This page covers its latest market performance, valuation, price trends and company information.
$102,67M | |
$3,50 | |
$18,79 | |
$3,05 | |
$3,45 | |
210,92K | |
209,11K | |
-- | |
$18,79 | |
$3,05 | |
-- | |
-- |
Conexeu Sciences Inc. (CNXU) is currently trading at $4,16 as of 2026-10-09 16:09:00, up 20,58% ($0,71) from the previous close of $3,45
During today's regular trading session, CNXU has traded between $3,05 and $18,79, with a trading volume of 210,92K shares. The current price is near the lower end of today's range.
Over the past seven days, Conexeu Sciences Inc. (CNXU) moved from $3,57 to $4,16, representing a gain of 16,53% ($0,59).
The stock traded between $3,05 and $4,21 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 199,47 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 7,1%
CNXU is currently trading at $4,16, placing it 7,1% of the way from its 52-week low of $3,05 to its 52-week high of $18,79. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Conexeu Sciences Inc is an early-stage medical technology company. The company develops and supplies collagen-based technologies that helps doctors and patients regenerate tissue naturally, safely, and effectively. The company is focused on developing regenerative biomaterials that address relative needs in wound care, dentistry, and aesthetics. The company seek to provide physicians with device-based solutions that improve healing, restore soft tissue, and enhance patient outcomes across multiple clinical settings. The company focuses durable, and growing addressable markets in regenerative aesthetics, wound care, 3D-printed tissue structures, veterinary wound repair, and dental soft-tissue regeneration.
| Industry | ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Conexeu Sciences Inc. (CNXU) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.